Related Experiment Video
Updated: Jul 6, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
Chronic acquired demyelinating polyneuropathies
1Phoenix Neurological Associates, 1331 North 7th Street, Suite 350, Phoenix, AZ 85006, USA. david.saperstein@gmail.com
Abstract:
Several entities can be put under the heading of chronic acquired demyelinating polyneuropathy. Future research will hopefully provide a greater understanding of pathophysiology, which may suggest the ideal way to classify and manage these patients. In the meantime, it is reasonable and useful to use clinical, laboratory, and electrodiagnostic data to classify patients in ways that facilitate identification and treatment. This article outlines an approach to the diagnosis and management of chronic acquired demyelinating polyneuropathies.
Related Concept Videos
Multiple Sclerosis l: Introduction
Diabetic Neuropathy
Poliomyelitis
Myasthenia Gravis ll: Pathophysiology
Parkinson's Disease: Overview
Peripheral Artery Disease I: Introduction

